Bioy: US public policy has so far this year been the biggest driver of share price performance and that is likely to continue ...

Real estate interval funds provide a liquidity transformation service for investors by issuing and redeeming shares that are ...

Equity markets tend to rise on anticipated rate cuts. In bond markets, falling interest rates mean lower yields, which pushes ...

In the thick of the busiest season for the real-estate industry, home prices are falling in some cities as high mortgage rates hammer those local markets. Homeowners are struggling to sell in markets ...

Hertz's stock (HTZ) is logging its second straight day of double-digit gains with a 47% jump on Thursday. The stock is now trading at $8.40 a share, more than double its closing level of $3.65 a share ...

The state of North Carolina will issue approximately $439.8 million in bonds to help finance and refinance federal aid highway projects.

The average price of a used car in the U.S. hovers at around $25,000, and the average price of a new car is nearly double that. Estimates on the increase in the price of new cars due to tariffs range ...

I am looking for suggestions on where to put $100,000. I have $1 million invested in the stock market for my retirement. My house and car are both paid off, and I have plenty of rainy-day money. I don ...

Social Security beneficiaries are going to face longer wait times at local field offices - and the federal government is going to be spending more money - as a result of the Social Security ...

The unusual disconnect is attributed to a more than 23% plunge in shares of UnitedHealth (UNH). The health insurer on Thursday slashed its full-year outlook and missed quarterly expectations for the ...

Schwab's first-quarter revenue increased to a record of $5.6 billion from $4.74 billion in the year-ago quarter, ahead of the analyst projection of $5.53 billion. Total client assets increased 9% over ...

Eli Lilly & Co.'s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...